Tech Company Financing Transactions
Carlsmed Funding Round
Carlsmed, based in La Jolla, secured $52.5 million from B Capital Group, U.S. Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
3/18/2024
Transaction Type
Venture Equity
Amount
$52,500,000
Round
Series C
Investors
B Capital Group (Lead Investor)
U.S. Venture Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the commercialization of the aprevo® personalized spine surgery platform for lumbar fusion procedures and the development of aprevo® for cervical fusions, which will launch in 2025.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4250 Executive Sq. 675
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Carlsmed is leveraging AI and predictive analytics to utilize prior outcomes data for personalizing the treatment of complex adult spinal deformities. The company's proprietary aprevo platform makes surgical plans and devices tailored to the precise medical situation of every individual patient.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Cordonnier
Chief Financial Officer
Alexander Arrow
Chief Information Officer
Shariq Hussain
Chief Operating Officer
Sharon Schulzki
Chief Technical Officer
Niall Casey
VP - Operations
Daryle Meyers
VP - Regulatory Affairs
Karen Liu
VP - Sales
Frank Fitzgerald
Browse more venture capital transactions:
Prev: 3/18/2024: Figure Markets venture capital transaction
Next: 3/18/2024: Work & Mother venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs